100 related articles for article (PubMed ID: 3648770)
1. Patterns of nausea, vomiting, and distress in patients receiving antineoplastic drug protocols.
Rhodes VA; Watson PM; Johnson MH; Madsen RW; Beck NC
Oncol Nurs Forum; 1987; 14(4):35-44. PubMed ID: 3648770
[No Abstract] [Full Text] [Related]
2. [Patient lack of knowledge about nausea in chemotherapy: becoming experts in their disease].
Seeling S
Pflege Z; 2005 Feb; 58(2):104-6. PubMed ID: 15754509
[No Abstract] [Full Text] [Related]
3. [The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients].
Perevodchikova NI; Volkova MA; Gorbunova VA; Manziuk LV; Marenich AF; Smirnova NB
Ter Arkh; 1996; 68(2):30-4. PubMed ID: 8771653
[TBL] [Abstract][Full Text] [Related]
4. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
Shih V; Wan HS; Chan A
Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
[TBL] [Abstract][Full Text] [Related]
5. Patterns of nausea and vomiting in chemotherapy patients: a preliminary study.
Rhodes VA; Watson PM; Johnson MH
Oncol Nurs Forum; 1985; 12(3):42-8. PubMed ID: 3847064
[No Abstract] [Full Text] [Related]
6. Anticipatory nausea and vomiting in an ambulatory medical oncology population.
Fetting JH; Wilcox PM; Iwata BA; Criswell EL; Bosmajian LS; Sheidler VR
Cancer Treat Rep; 1983 Dec; 67(12):1093-8. PubMed ID: 6652626
[TBL] [Abstract][Full Text] [Related]
7. [Predictive factors of nausea/vomiting of breast cancer patients receiving FEC and AC chemotherapy].
Nomura H; Kawakami H; Nagai S; Shinohara T; Imoto S; Isaka H
Gan To Kagaku Ryoho; 2008 Jun; 35(6):941-6. PubMed ID: 18633221
[TBL] [Abstract][Full Text] [Related]
8. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced nausea, vomiting, and fatigue--the role of individual differences related to sensory perception and autonomic reactivity.
Zachariae R; Paulsen K; Mehlsen M; Jensen AB; Johansson A; von der Maase H
Psychother Psychosom; 2007; 76(6):376-84. PubMed ID: 17917474
[TBL] [Abstract][Full Text] [Related]
10. [The management of vomiting and nausea with zofran during the chemotherapy of malignant tumors].
Seliuzhitskiĭ IV; Eliseev SN; Ivanov AI
Voen Med Zh; 1994 Oct; (10):34-6. PubMed ID: 7831851
[No Abstract] [Full Text] [Related]
11. Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
Dix S; Cord M; Howard S; Coon J; Belt R; Geller R
Bone Marrow Transplant; 1999 Sep; 24(5):561-6. PubMed ID: 10482943
[TBL] [Abstract][Full Text] [Related]
12. The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer.
Williams SA; Schreier AM
Oncol Nurs Forum; 2004; 31(1):E16-23. PubMed ID: 14722602
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
Warr DG; Hesketh PJ; Gralla RJ; Muss HB; Herrstedt J; Eisenberg PD; Raftopoulos H; Grunberg SM; Gabriel M; Rodgers A; Bohidar N; Klinger G; Hustad CM; Horgan KJ; Skobieranda F
J Clin Oncol; 2005 Apr; 23(12):2822-30. PubMed ID: 15837996
[TBL] [Abstract][Full Text] [Related]
14. Oral ondansetron: a useful addition to the supportive care armamentarium?
Hesketh PJ
Am J Clin Oncol; 1994 Apr; 17(2):147-9. PubMed ID: 8141106
[No Abstract] [Full Text] [Related]
15. [Metoclopramide in the prevention of nausea and vomiting caused by cytostatics].
Swierz J; Krzakowski M; Szutkowski Z; Nowakowski W
Wiad Lek; 1985 May; 38(10):715-8. PubMed ID: 3901527
[No Abstract] [Full Text] [Related]
16. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant.
Grote T; Hajdenberg J; Cartmell A; Ferguson S; Ginkel A; Charu V
J Support Oncol; 2006 Sep; 4(8):403-8. PubMed ID: 17004515
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer].
Taguchi T; Tsukamoto F; Watanabe T; Yoneda K; Takamura Y; Hojo S; Shiba E; Noguchi S
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1163-70. PubMed ID: 10431583
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.
Yonemura M; Katsumata N; Hashimoto H; Satake S; Kaneko M; Kobayashi Y; Takashima A; Kato Y; Takeuchi M; Fujiwara Y; Yamamoto H; Hojo T
Jpn J Clin Oncol; 2009 Jul; 39(7):443-8. PubMed ID: 19395466
[TBL] [Abstract][Full Text] [Related]
20. Delayed chemotherapy-induced nausea in women treated for breast cancer.
Dibble SL; Isreal J; Nussey B; Casey K; Luce J
Oncol Nurs Forum; 2003; 30(2):E40-7. PubMed ID: 12692669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
